주식/증권 📈 긍정적

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now

Yahoo Finance 2026/06/10 14:38:00 6회

요약

NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.

원문 기사 보기

관련 뉴스

Hedge funds dump tech stocks at fastest pace on record – Goldman

Dynatrace names Riedel, Streetman to board after Starboard Value talks

Sable Offshore prices stock, convertible note offerings to repay debt

iShares TIPS Bond ETF declares monthly distribution of $1.0580

뉴스 목록으로